Semin Reprod Med 2014; 32(03): 230-240
DOI: 10.1055/s-0034-1371095
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Development of Evidenced-Based Guidelines for PCOS and Implications for Community Health

Marie Misso
1   Monash Centre for Health Research and Implementation—MCHRI, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia
,
Jacqueline Boyle
1   Monash Centre for Health Research and Implementation—MCHRI, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia
,
Robert Norman
2   Robinson Institute, University of Adelaide, North Adelaide, South Australia, Australia
,
Helena Teede
1   Monash Centre for Health Research and Implementation—MCHRI, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2014 (online)

Abstract

Despite the prevalence and health implications of polycystic ovary syndrome (PCOS), key evidence practice gaps exist including delayed diagnosis, inconsistent management, inadequate support for lifestyle change, and limited attention to psychological and metabolic features. Key contributors to these gaps include a lack of awareness and absence of evidence-based guidelines (EBGs) to inform consumers and health professionals. Intervention was needed to improve awareness, patient experience, early diagnosis, self-management, complication screening, and treatment across reproductive, metabolic, and psychological features driving the authors to establish a national PCOS Alliance. All relevant stakeholders including consumers, researchers, and clinicians codeveloped a vision and based on compellingly need and lobbying, the Australian government funded development of EBGs meeting international standards. To maximize impact, a national dissemination and implementation program was delivered with ongoing evaluation. Activities were recognized by the U.S. National Institute of Health and are being scaled up with the World Health Organization.

 
  • References

  • 1 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25 (2) 544-551
  • 2 Boyle JA, Cunningham J, O'Dea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia. Med J Aust 2012; 196 (1) 62-66
  • 3 Davis SR, Knight S, White V, Claridge C, Davis BJ, Bell R. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women. Gynecol Endocrinol 2002; 16 (6) 443-446
  • 4 Hickey M, Doherty DA, Atkinson H , et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod 2011; 26 (6) 1469-1477
  • 5 Hickey M, Sloboda DM, Atkinson HC , et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab 2009; 94 (10) 3714-3720
  • 6 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588) 685-697
  • 7 Fauser BCJM, Tarlatzis BC, Rebar RW , et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97 (1) 28-38.e25
  • 8 Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16 (4) 347-363
  • 9 Wild RA, Carmina E, Diamanti-Kandarakis E , et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010; 95 (5) 2038-2049
  • 10 Moran LJ, Deeks AA, Gibson-Helm ME, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod 2012; 27 (7) 2082-2088
  • 11 Deeks AA, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?. Hum Reprod 2011; 26 (6) 1399-1407
  • 12 Teede HJ, Joham AE, Paul E , et al. Longitudinal weight gain in women identified with Polycystic Ovary Syndrome: results of an observational study in young women. Obesity 2013; 21 (8) 1526-1532
  • 13 Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006; 20 (2) 235-244
  • 14 Teede HJ, Hutchison SK, Zoungas S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab 2007; 18 (7) 273-279
  • 15 Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93 (7) 2421-2423
  • 16 Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005; 90 (8) 4650-4658
  • 17 Teede HJ, Stuckey BGA. Polycystic ovary syndrome and abnormal glucose tolerance. Med J Aust 2007; 187 (6) 324-325
  • 18 Azziz R, Carmina E, Dewailly D , et al; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91 (11) 4237-4245
  • 19 Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine 2006; 30 (1) 19-26
  • 20 Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005; 62 (3) 289-295
  • 21 Teede HJ, Misso ML, Deeks AA , et al; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (6) S65-S112
  • 22 Jean Hailes for Women's Health. Evidence-Based Guidelines for Assessment and Management of Polycystic Ovary Syndrome. Melbourne: Jean Hailes for Women's Health on behalf of the PCOS Australian Alliance; 2011
  • 23 Misso M, Teede H. Evidence based guideline (EBG) development: a practical guide. In: Ilic D, , ed. Knowledge Transfer: Practices, Types and Challenges. New York: Nova Publishers; 2012
  • 24 Thomson R, Lavender M, Madhok R. How to ensure that guidelines are effective. BMJ 1995; 311 (6999) 237-242
  • 25 Turner T, Misso M, Harris C, Green S. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci 2008; 3 (45) 45
  • 26 Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318 (7182) 527-530
  • 27 Brouwers MC, Kho ME, Browman GP , et al; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182 (18) E839-E842
  • 28 The AGREE Enterprise. The Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. Available at: http://www.agreetrust.org/ . Accessed September 2011
  • 29 National Medical Health and Medical Research Council. Clinical Practice Guidelines Portal. Available at: http://www.clinicalguidelines.gov.au/ . Accessed November 6, 2013
  • 30 Harris C, Turner T, Wilkinson F. Guideline Development Toolkit. Centre for Clinical Effectiveness, Southern Health, Australia, Melbourne; 2008
  • 31 Scottish Intercollegiate Guideline Network. SIGN 50: A Guideline Developers' Handbook. SIGN; 2004
  • 32 Scott IA, Guyatt GH. Clinical practice guidelines: the need for greater transparency in formulating recommendations. Med J Aust 2011; 195 (1) 29-33
  • 33 National Health and Medical Research Council. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Australia: NHMRC; 1999
  • 34 Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, Green SE. Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 2008; 189 (7) 394-399
  • 35 Centre for Clinical Effectiveness. Critical Appraisal Templates: CCE, Southern Health; 2010
  • 36 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011
  • 37 Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (7) e1000097
  • 38 National Health and Medical Research Council. NHMRC Additional Levels of Evidence and Grades for Recommendations for Developers of Guidelines. Australia: NHMRC; 2009
  • 39 Moran LJ, Ko H, Misso M , et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Hum Reprod Update 2013; 19 (5) 432
  • 40 Misso M, Costello M, Garrubba M , et al. Metformin versus clomiphene citrate for infertility in non-obese women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012; 19 (1) 2-11
  • 41 Misso M, Teede H, Hart R , et al. Clomiphene citrate and metformin for infertility in PCOS:systematic review. Trends Endocrinol Metab 2012; 23 (10) 533-535
  • 42 Moran LJ, Ko H, Misso M , et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet 2013; 113 (4) 520-545
  • 43 Misso ML, Wong JL, Teede HJ , et al. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012; 18 (3) 301-312
  • 44 Costello MF, Misso ML, Wong J , et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol 2012; 52 (4) 400-403